Modulation of PPAR-γ, SREBP-1c and inflammatory mediators by luteolin ameliorates β-cell dysfunction and renal damage in a rat model of type-2 diabetes mellitus
Syed Ilyas Shehnaz, Anitha Roy, R. Vijayaraghavan, Senthilkumar Sivanesan, N. Pazhanivel
Topics & Concepts
Internal medicineEndocrinologyStreptozotocinInsulin resistancePioglitazoneLuteolinMedicineDiabetes mellitusType 2 Diabetes MellitusGlucose homeostasisType 2 diabetesChemistryAntioxidantBiochemistryQuercetinCholesterol and Lipid MetabolismNatural Antidiabetic Agents StudiesPeroxisome Proliferator-Activated Receptors